Jiang Qian
Fudan Eye & ENT Hospital · Peking University People's Hospital(北京大学人民医院)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jiang Qian as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:52 UTC. Open this list on ClinicalTrials.gov
- Early Ph1NCT06424301 · Targeting NUDT21 siRNA Drugs for Patients With Refractory RetinoblastomaEye & ENT Hospital of Fudan University · recruiting · Retinoblastoma, Refractory · study director
- N/ANCT04903678 · Intrathecal Chemotherapy for Central Nervous System Metastasis in RetinoblastomaEye & ENT Hospital of Fudan University · recruiting · Retinoblastoma, Extraocular · principal investigator
- N/ANCT04016675 · Neoadjuvant Radiotherapy for Malignant Lacrimal Sac TumorsEye & ENT Hospital of Fudan University · recruiting · Malignant Tumor of Lacrimal Drainage Structure · study chair
- Ph3NCT03722420 · Randomized Evaluation of Radotinib Versus Imatinib in Phase III Study for Efficacy With Chinese Patients (RERISE China)Il-Yang Pharm. Co., Ltd. · active not recruiting · Chronic Myeloid Leukemia, Chronic Phase · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:52 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 12 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in chronic myeloid leukemia.